Postal Ballot Notice
In compliance to Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Regulations, 2015; we enclose herewith the Postal Ballot Notice and Form which is sent by the Company to its Registered Shareholders whose names appear on the Register of Members / List of Beneficial Owners as on Friday, December 7, 2018 i.e., the cut-off date for determining the eligibility for voting and seeking their consent for the matter(s) stated in the Notice. Outcome of Board Meeting
In compliance to Regulation 30 read with Schedule III of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of the Company, at its Meeting held on Wednesday, December 5, 2018; have considered and approved the Postal Ballot Notice. Board Meeting Intimation for Intimation Of The 169Th Board Meeting
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/12/2018 ,inter alia, to consider and approve To consider and approve the Postal Ballot Notice or Notice of the Extra-Ordinary General Meeting of the Shareholders of the Company as the Board will decide. Appointment Of Company Secretary Cum Compliance Officer
In compliance to the provisions of Section 203 of the Companies Act, 2013 and Rules made thereunder and Regulation 6(1) of the SEBI Listing Regulations, 2015; we wish to inform that the Company had appointed Ms. Priyanka Arun Chaturvedi (ACS 55917) as the Company Secretary Cum Compliance Officer of the Company. Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance to Regulation 47(1)(b) of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for Quarter and Half year ended September 2018; as approved by the Board in its Meeting held on Monday, November 5, 2018; published in Navshakti and Free-press Journal on November 6, 2018. Outcome of Board Meeting
In compliance to Regulation 30 read with Schedule III of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Monday, November 5, 2018; had considered and approved :- 1. regularized the Sexual Harassment Policy; 2. the Vigil Mechanism Policy of the Company. Unaudited Financial Results For Quarter And Half Year Ended September 30, 2018
In compliance to Regulation 33 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Monday, November 5, 2018; had considered and approved the Unaudited Financial Results of the Company for Quarter and half year ended September 30, 2018; along with the Statement of Assets and Liabilities and Limited Review Report issued... Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance to Regulation 47 of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Monday, November 5, 2018; published in Navshakti & Free-press Journal on October 28, 2018. Board Meeting Intimation for Intimation Of The Board Meeting
FREDUN PHARMACEUTICALS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2018 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI Listing Regulations, 2015 we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 5, 2018 at 3:00 P.M. at the Registered Office Compliance Certificate Under Regulations 40(9) & 40(10) Of SEBI Listing Regulations, 2015 For Half Year Ended September 30, 2018
In compliance to Regulation 40(9) & 40(10) of SEBI Listing Regulations, 2015; we furnish the certificate for the half year ended September 30, 2018 of Fredun Pharmaceuticals Limited as issued by Rajendra & Co., Practising Company Secretaries.